BTAIVSHAE• 3 Months (Normalized)
BTAI vs HAE (BioXcel Therapeutics Inc. vs Haemonetics Corporation)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
HAE Performance $104.68
+39.8%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
-39.8 pts
HAE outperforming by 39.80 percentage points
BTAIHAE
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BTAI Price | BTAI Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $- | $104.68 | +39.80% | - | |
| Oct 02, 2026 | $- | $104.68 | +39.80% | - | |
| Oct 01, 2026 | $- | $104.37 | +39.38% | - | |
| Sep 30, 2026 | $- | $105.30 | +40.63% | - | |
| Sep 29, 2026 | $- | $105.80 | +41.29% | - | |
| Sep 28, 2026 | $- | $105.79 | +41.28% | - | |
| Sep 25, 2026 | $- | $105.30 | +40.63% | - | |
| Sep 24, 2026 | $0.04 | -96.61% | $- | - | |
| Sep 23, 2026 | $0.05 | -95.67% | $106.82 | +42.65% | -138.32% |
| Sep 22, 2026 | $0.04 | -95.71% | $108.52 | +44.93% | -140.64% |
| Sep 21, 2026 | $0.06 | -94.09% | $108.73 | +45.21% | -139.30% |
| Sep 18, 2026 | $0.06 | -94.42% | $108.40 | +44.76% | -139.18% |
| Sep 17, 2026 | $0.08 | -92.78% | $107.60 | +43.70% | -136.48% |
| Sep 16, 2026 | $0.07 | -93.57% | $106.24 | +41.88% | -135.45% |
| Sep 15, 2026 | $0.04 | -95.70% | $106.20 | +41.83% | -137.53% |
Page 1 of 5